EyePoint (EYPT) Amortizatization of Intangibles (2010 - 2021)
EyePoint (EYPT) reported Amortizatization of Intangibles of $166000.0 for Q4 2021, down 21.33% on a YoY basis from $211000.0 in Q4 2020, and up 2.47% sequentially from $162000.0 in Q3 2021.
EyePoint (EYPT) Amortizatization of Intangibles (2010 - 2021) Analysis & Trends
EyePoint (EYPT) has 11 years of Amortizatization of Intangibles data on file, last reported at $166000.0 in Q4 2021.
- For the quarter ending Q4 2021, Amortizatization of Intangibles fell 21.33% year-over-year to $166000.0; the trailing twelve-month figure through Dec 2021 stood at $628000.0 (down 15.7% YoY), and the FY2021 full-year result was $628000.0, down 15.7% from the prior year.
- Amortizatization of Intangibles climbed to $166000.0 in Q4 2021, from $162000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $211000.0 in Q4 2020 to a low of -$2000.0 in Q1 2017.
- A 4-year average of $147000.0 and a median of $162000.0 in 2021 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles sank 111.11% in 2017 and surged 103.57% in 2020, its largest moves.
- Tracing EYPT's Amortizatization of Intangibles over 4 years: stood at -$2000.0 in 2017, then soared by 8400.0% to $166000.0 in 2019, then increased by 27.11% to $211000.0 in 2020, then slipped by 21.33% to $166000.0 in 2021.
- Business Quant data shows EYPT's Amortizatization of Intangibles at $166000.0 in Q4 2021, $162000.0 in Q3 2021, and $153000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | EyePoint | 1.07 Mn | -221.48 Mn | 168,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 166,000.00 |
| Dec 31, 2021 | 166,000.00 |
| Sep 30, 2021 | 162,000.00 |
| Sep 30, 2021 | 162,000.00 |
| Jun 30, 2021 | 153,000.00 |
| Jun 30, 2021 | 153,000.00 |
| Mar 31, 2021 | 147,000.00 |
| Mar 31, 2021 | 147,000.00 |
| Dec 31, 2020 | 211,000.00 |
| Dec 31, 2020 | 211,000.00 |
| Sep 30, 2020 | 186,000.00 |
| Sep 30, 2020 | 186,000.00 |
| Jun 30, 2020 | 177,000.00 |
| Jun 30, 2020 | 177,000.00 |
| Mar 31, 2020 | 171,000.00 |
| Mar 31, 2020 | 171,000.00 |
| Dec 31, 2019 | 166,000.00 |
| Dec 31, 2019 | 166,000.00 |
| Sep 30, 2019 | 160,000.00 |
| Sep 30, 2019 | 160,000.00 |